AHRQ, FDA to study cardiovascular risks of ADHD drugs

The Department of Health and Human Services' Agency for Healthcare

Read the full 104 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE